Inhibitory effects of 2,6-di-O-methyl-3-O-acetyl-β-cyclodextrins with various degrees of substitution of acetyl group on macrophage activation and endotoxin shock induced by lipopolysaccharide

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 56, Issue 1-2, 2006, Pages 75-79

  Motoyama, Keiichi ^a   Arima, Hidetoshi ^a   Hirayama, Fumitoshi ^a   Uekama, Kaneto ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Degree of substitution; Dimethylacetyl cyclodextrin; Endotoxin shock; Lipopolysaccharide; Nitric oxide

Indexed keywords

EID: 34848860435     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-006-9064-7     Document Type: Conference Paper

References (30)

1. J.C. Marshall: Nat. Rev. Drug Discov. 2, 391 (2003).
2. N.C. Riedemann, R.F. Guo, and P.A. Ward: Nat. Med. 9, 517 (2003).
3. D.P. Healy: Ann. Pharmacother. 36, 648 (2002).
4. K. Kaneko, R. Ueda, H. Nemoto, H. Iijima, and T. Yoshimura: Xenobiotica 33, 323 (2003).
5. R. Karima, S. Matsumoto, H. Higashi, and K. Matsushima: Mol. Med. Today 5, 123 (1999).
6. W.H. Fissell, L. Lou, S. Abrishami, D.A. Buffington, and H.D. Humes: J. Am. Soc. Nephrol. 14, 454 (2003).
7. D.C. Angus, W.T. Linde-Zwirble, G. Clermont, M.F. Griffin, and R.H. Clark: Am. J. Respir. Crit. Care Med. 164, 1154 (2001).
8. D.C. Angus, M.C. Birmingham, R.A. Balk, P.J. Scannon, D. Collins, J.A. Kruse, D.R. Graham, H.V. Dedhia, S. Homann, and N. MacIntyre: JAMA 283, 1723 (2000).
9. D.L. Dunn: Surg. Infect. 1, 227 (2000).
10. K. Uekama and M. Otagiri: Crit. Rev. Ther. Drug Carrier Syst. 3, 1 (1987).
11. L. Szente and J. Szejtli: Adv. Drug Deliv. Rev. 36, 17 (1999).
12. Y. Ohtani, T. Irie, K. Uekama, K. Fukunaga, and J. Pitha: Eur. J. Biochem. 186, 17 (1989).
13. F. Fauvelle, J.C. Debouzy, S. Crouzy, M. Goschl, and Y. Chapron: J. Pharm. Sci. 86, 935 (1997).
14. K. Simons and R. Ehehalt: J. Clin. Invest. 110, 597 (2002).
15. F. Van Laethem and O. Leo: Curr. Mol. Med. 2, 557 (2002).
16. F. Galbiati, B. Razani, and M.P. Lisanti: Cell 106, 403 (2001).
17. R.G. Anderson and K. Jacobson: Science 296, 1821 (2002).
18. H. Arima, Y. Nishimoto, K. Motoyama, F. Hirayama, and K. Uekama: Pharm. Res. 18, 1167 (2001).
19. K. Motoyama, H. Arima, Y. Nishimoto, K. Miyake, F. Hirayama, and K. Uekama: FEBS Lett. 579, 1707 (2005).
20. H. Arima, K. Motoyama, A. Matsukawa, Y. Nishimoto, F. Hirayama and K. Uekama: Biochem. Pharmacol. 70, 1506 (2005).
21. B.W. Muller and U. Brauns: J. Pharm. Sci. 75, 571 (1986).
22. C.T. Rao, J. Pitha, B. Lindberg, and J. Lindberg: Carbohydr. Res. 223, 99 (1992).
23. K. Harata and C.T. Rao: Carbohydr. Res. 247, 83 (1993).
24. F. Hirayama, S. Mieda, Y. Miyamoto, H. Arima, and K. Uekama: J. Pharm. Sci. 88, 970 (1999).
25. N. Ono, H. Arima, F. Hirayama, and K. Uekama: Biol. Pharm. Bull. 24, 395 (2001).
26. K. Hamasaki, K. Kogure, and K. Ohwada: Toxicon 34, 490 (1996).
27. D.J. Stuehr and C.F. Nathan: J. Exp. Med. 169, 1543 (1989).
28. K. Uekama, F. Hirayama, and T. Irie: Chem. Rev. 98, 2045 (1998).
29. M.E. Brewster, K. Estes, T. Loftsson, R. Perchalski, H. Derendorf, G. Mullersman, and N. Bodor: J. Pharm. Sci. 77, 981 (1988).
30. B. Anton, B. Mark, C. Ken, K.C. John, E. Jan, F. Helen, J.M. Elizabeth, W.M. Alan, P. Ronald, C.R. David, and Q.Z. Ming: Angew. Chem. 114, 276 (2002).